Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/15/2012WO2012007555A3 New ziprasidone salts and methods of their formation
03/15/2012WO2012006516A3 Protein kinase c activators and anticoagulant for the treatment of stroke
03/15/2012WO2012006100A3 Methods and compositions for enhancing stem cell mobilization
03/15/2012WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/15/2012WO2011163554A3 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
03/15/2012WO2011163430A9 Polymorphs of osi-906
03/15/2012WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment
03/15/2012WO2011158110A3 Cilostazol cocrystals and compositions
03/15/2012WO2011156803A3 Anti-cellulite composition and method of treating cellulite
03/15/2012WO2011150286A3 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
03/15/2012WO2011141791A3 Extended release formulations of desvenlafaxine base
03/15/2012WO2011140446A3 Pharmaceutical formulations
03/15/2012WO2011139886A3 Preparation of febuxostat
03/15/2012WO2011139868A3 Method for treating esophageal cancer
03/15/2012WO2011139348A3 Uses of phospholipid conjugates of synthetic tlr7 agonists
03/15/2012WO2011138197A3 Novel low concentration meloxicam tablets
03/15/2012WO2011138037A3 Solid tapentadol in non-crystalline form
03/15/2012WO2011133729A3 Anti-viral compounds
03/15/2012WO2011133659A3 Inhibitors of hif and angiogenesis
03/15/2012WO2011132008A3 Controlled release pharmaceutical composition
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012WO2011127465A3 Ship inhibitors and uses thereof
03/15/2012WO2011124570A3 Oral film formulation
03/15/2012WO2011121317A9 Imidazothiadiazoles for use as kinase inhibitors
03/15/2012WO2011120182A3 Use of at least one dialkyl thiosulfonate or thiosulfinate for reducing the number of apicomplexa in an animal
03/15/2012WO2011118976A3 Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
03/15/2012WO2011112893A3 Compositions for ameliorating cell proliferative disorders and methods of making and using them
03/15/2012WO2011103552A3 Amp derivatives for treating cardiac diseases
03/15/2012WO2011086182A3 Pramipexole extended release tablets
03/15/2012WO2011077169A3 Pharmaceutical preparation comprising sufentanil
03/15/2012WO2011073408A3 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
03/15/2012WO2011070152A3 Phenylated 3-deazauridine analogues at the c3 position as antiviral compounds
03/15/2012WO2011018763A8 Combination of proanthocyanidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis
03/15/2012WO2011014255A8 Treatment of crohn's disease with laquinimod
03/15/2012WO2002033044A9 Methods of high-throughput screening for internalizing antibodies
03/15/2012US20120065641 Methods and devices for repairing bone defects
03/15/2012US20120065614 Polyionic transitional metal phosphorescent complex/polymer hybrid systems for bioimaging and sensing applications
03/15/2012US20120065398 Method for producing 3-amidinophenylalanine derivatives
03/15/2012US20120065368 Cyclodextrin-based polymers for therapeutics delivery
03/15/2012US20120065273 Tto-based wide spectrum therapeutics, disinfectants & anesthetics for use in aquaculture
03/15/2012US20120065271 Method of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065268 High Concentration Baclofen Preparations
03/15/2012US20120065267 Compositions including 3,5-l-t2 and methods of use thereof
03/15/2012US20120065266 Oral composition
03/15/2012US20120065265 Alpha-2-delta ligands for non-restorative sleep
03/15/2012US20120065264 SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID
03/15/2012US20120065263 Retrovirus-infection inhibitor
03/15/2012US20120065262 Composition for preventing hair loss or for stimulating hair growth
03/15/2012US20120065261 Creatine compositions for skin treatment
03/15/2012US20120065260 Novel compounds
03/15/2012US20120065259 Heat assisted lidocaine and tetracaine for transdermal analgesia
03/15/2012US20120065258 Stable prostaglandin-containing compositions
03/15/2012US20120065257 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
03/15/2012US20120065256 Milbemycin compounds and treatment of dermatological disorders in humans therewith
03/15/2012US20120065255 Cabazitaxel formulations and methods of preparing thereof
03/15/2012US20120065254 C5A binding nucleic acids and the use thereof
03/15/2012US20120065252 Engineered nucleic acids and methods of use thereof
03/15/2012US20120065251 Mir-21 promoter driven targeted cancer therapy
03/15/2012US20120065250 siRNA Targeting Apolipoprotein B (APOB)
03/15/2012US20120065249 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
03/15/2012US20120065248 Methods and compositions involving mirna and mirna inhibitor molecules
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065246 Rna molecules and therapeutic uses thereof
03/15/2012US20120065245 Regulation of hematopoietic stem cell functions through micrornas
03/15/2012US20120065244 Oligomers
03/15/2012US20120065243 Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
03/15/2012US20120065242 POLYMERIC NANO-PARTICLES FOR siRNA DELIVERY USING CHARGE INTERACTION AND COVALENT BONDING
03/15/2012US20120065241 Therapeutic compounds for diseases and disorders
03/15/2012US20120065240 Method for treating nervous system disorders and conditions
03/15/2012US20120065238 Allantoin-containing skin cream
03/15/2012US20120065237 Methods for treating transthyretin amyloid diseases
03/15/2012US20120065236 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065235 Compounds for treating proliferative disorders
03/15/2012US20120065234 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
03/15/2012US20120065233 Tyrosine kinase inhibitors
03/15/2012US20120065232 Photostabilization of retinoids with alkoxycrylene compounds
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065230 Nitroxide Free Radical Synergized Antineoplastic Agents
03/15/2012US20120065228 Compositions and methods for treating, controlling, reducing, or ameliorating ocular inflammatory with lower risk of increased intraocular pressure
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065226 Salts of tiotropium with 10-camphorsulfonic acid
03/15/2012US20120065225 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
03/15/2012US20120065224 Pyrrolo[3,2-c) pyridine derivatives and processes for the preparation thereof
03/15/2012US20120065223 Solid forms of a chemokine receptor antagonist and methods of use thereof
03/15/2012US20120065222 Devices and methods for reducing scar tissue formation
03/15/2012US20120065221 Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
03/15/2012US20120065220 Tamper Resistant Dosage Form Comprising An Anionic Polymer
03/15/2012US20120065219 Spirocyclic azaadamantane derivatives and methods of use
03/15/2012US20120065218 Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
03/15/2012US20120065217 Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065215 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065214 Compounds and their uses 708
03/15/2012US20120065213 C-met protein kinase inhibitors
03/15/2012US20120065212 Heteroarylmethyl amides
03/15/2012US20120065211 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
03/15/2012US20120065210 Substituted hexahydropyrrolo[1,2-c]imidazolones
1 ... 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 ... 7860